AC
SNY icon

Alexandria Capital’s Sanofi SNY Stock Holding History

Alexandria Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-115
Closed -$6K – 611
2017
Q2 		$6K Hold
115
– – ﹤0.01% 472
2017
Q1 		$5K Hold
115
– – ﹤0.01% 485
2016
Q4 		$5K Hold
115
– – ﹤0.01% 478
2016
Q3 		$4K Hold
115
– – ﹤0.01% 512
2016
Q2 		$5K Hold
115
– – ﹤0.01% 486
2016
Q1 		$5K Hold
115
– – ﹤0.01% 497
2015
Q4 		$5K Hold
115
– – ﹤0.01% 534
2015
Q3 		$5K Buy
+115
New +$5.86K ﹤0.01% 479
2015
Q2 		– Sell
-939
Closed -$46K – 639
2015
Q1 		$46K Buy
+939
New +$44.9K 0.02% 210

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alexandria Capital's SNY Position: Q3 2017 in Review

Alexandria Capital sold out of Sanofi (SNY) in Q3 2017, closing a stake of 115 shares — an estimated $6K sold.

Alexandria Capital first reported a position in SNY in Q1 2015 and held it in 9 quarters. The position peaked at $46K in Q1 2015. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2017.

  • Alexandria Capital reported no remaining Sanofi position as of Q3 2017 after selling out during the quarter.
  • Alexandria Capital sold 115 Sanofi shares in Q3 2017, an estimated $6K.
  • Alexandria Capital first reported a position in Sanofi in Q1 2015 and held it in 9 quarters.
  • Alexandria Capital's Sanofi position peaked at $46K in Q1 2015.
  • 485 funds tracked by Wall St. Rank held Sanofi as of Q3 2017.

Based on Alexandria Capital's 13F filing for Q3 2017, filed 27 Oct 2017.